Medical Equipment

Global Lyme Disease Testing Market Set To Expand To $16.46 Billion By 2030 At 9% CAGR

April 14, 2026April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Lyme Disease Testing Market Between 2026 And 2030?

The lyme disease testing market size has experienced robust growth in recent years. It is projected to expand from $10.68 billion in 2025 to $11.67 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.3%. The historic increase in this market can be attributed to the rising incidence of lyme disease, limited awareness concerning early diagnosis, reliance on conventional serological testing methods, the increasing prevalence of hospital-based diagnostics, and growing research efforts in tick-borne diseases.

The lyme disease testing market size is anticipated to experience robust expansion over the coming years. This market is projected to reach a value of $16.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. The projected increase during this period is driven by factors such as the integration of AI-assisted diagnostics, the rise in popularity of home-testing kits, the development of multi-disease panels, increased government investment in tick-borne disease monitoring, and the adoption of cloud-based laboratory data management. Key developments expected during the forecast timeframe encompass the wider deployment of point-of-care testing, the availability of home-based lyme disease diagnostics, the emergence of multi-pathogen tick-borne panels, the increased use of rapid test kits, and the implementation of personalized diagnostic protocols.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/lyme-disease-testing-global-market-report

Which Strong Drivers Are Impacting The Lyme Disease Testing Market Growth?

The increasing incidence of tick-borne diseases is projected to boost the expansion of the lyme disease testing market moving forward. These illnesses are a category of diseases spread to humans via bites from infected ticks, which are tiny, blood-consuming parasites typically found in grassy, forested, or countryside environments. The growing need for treatments for tick-borne illnesses stems from the widening geographical distribution of ticks due to climate change, resulting in increased exposure and infection rates. As the main method of transmitting Lyme disease, tick-borne illnesses drive the demand for Lyme disease testing, making early detection and diagnosis crucial for effectively handling the increasing number of infection cases. For example, reports from March 2025 by the U.S. Centers for Disease Control and Prevention (CDC), a federal public health agency based in the U.S., indicated that in 2023, over 89,000 cases of Lyme disease were recorded. This highlights a persistent significant impact from tick-borne illnesses compared to earlier years. Consequently, the escalating occurrence of tick-borne illnesses is propelling the expansion of the lyme disease testing market.

Which Segment Classifications Are Used In The Lyme Disease Testing Market Segment Analysis?

The lyme disease testing market covered in this report is segmented –

1) By Test Type: Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types

2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies

3) By Disease Stage: Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection

4) By Sample Type: Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples

5) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations

Subsegments:

1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)

2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)

3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests

4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools

Which Trends Are Contributing To Changes In The Lyme Disease Testing Market?

Major companies operating in the Lyme disease testing market are concentrating on technological advancements in diagnostic instruments to enhance test precision, reduce processing times, and enable the identification of the disease in its early stages. Diagnostic tools refer to medical devices, kits, or technologies utilized to confirm the presence of Lyme disease by identifying specific antibodies, antigens, or genetic material associated with the Borrelia burgdorferi bacteria. For instance, in August 2024, EpitogenX Ltd., a UK-based biotechnology company, disclosed the introduction of an advanced Lyme Disease Diagnostic Kit. This is an ELISA-based assay engineered using their proprietary EpitoGen platform. It incorporates approximately ~120 distinct Borrelia epitopes, providing high specificity and sensitivity, and is designated for research use (RUO). It facilitates early, strain-specific detection and can be customized for various laboratory applications. Created for research and diagnostic laboratories, it is optimal for improving detection accuracy and allowing deeper insights into Lyme disease.

Which Firms Are Contributing To The Lyme Disease Testing Market Ecosystem?

Major companies operating in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMÉRIEUX, Quidel Corporation, Bio Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Lyme Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG, Hologic Inc., Seegene Inc.

Get The Full Lyme Disease Testing Market Report:

https://www.thebusinessresearchcompany.com/report/lyme-disease-testing-global-market-report

Which Geographic Region Dominates The Lyme Disease Testing Market?

North America was the largest region in the lyme disease testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lyme Disease Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lyme-disease-testing-global-market-report

Browse Through More Reports Similar to the Global Lyme Disease Testing Market 2026, By The Business Research Company

Biologics Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Covid 19 Saliva Screening Test Potential Market Report 2026

https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

Typhoid Antibody Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/typhoid-antibody-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795